31 results
CORRESP
COCP
Cocrystal Pharma Inc
19 Dec 11
Correspondence with SEC
12:00am
, qualifications, attributes or skills of directors and nominees" on an individual basis. Please revise your disclosure to address the requirements of 401 … (e)(1). Your disclosure should address the specific experience, qualifications, attributes and skills of each director or nominee. A mere reference
10-K
e53q087q0fsrdhxg
31 Mar 09
Annual report
12:00am
POS AM
b8zyprqs43nfk9lyf3
14 Jul 10
Prospectus update (post-effective amendment)
12:00am